Cargando…
Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis
BACKGROUND AND AIM: The effect of cannabis use on chronic liver disease (CLD) from Hepatitis C Virus (HCV) infection, the most common cause of CLD, has been controversial. Here, we investigated the impact of cannabis use on the prevalence of CLD among HCV infected individuals. METHODS: We analyzed h...
Autores principales: | Adejumo, Adeyinka Charles, Adegbala, Oluwole Muyiwa, Adejumo, Kelechi Lauretta, Bukong, Terence Ndonyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174743/ https://www.ncbi.nlm.nih.gov/pubmed/30345261 http://dx.doi.org/10.1155/2018/9430953 |
Ejemplares similares
-
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study
por: Adejumo, Adeyinka Charles, et al.
Publicado: (2017) -
3442 Among Hospitalized Patients, Cannabis use is Associated with Reduced risk of Clostridium Difficile infection
por: Adejumo, Adeyinka Charles, et al.
Publicado: (2019) -
3445 Cannabis use and risk of H. pylori infection; analysis of inpatients and residents of the US.
por: Adejumo, Adeyinka Charles, et al.
Publicado: (2019) -
2440: Among heart failure patients, cannabis use is an independent predictor of hospitalization and discharge against medical advice: Data from the 2012 Nationwide Emergency Department Sample (NEDS)
por: Adejumo, Adeyinka C., et al.
Publicado: (2018) -
Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States
por: Adejumo, Adeyinka Charles, et al.
Publicado: (2019)